Cargando…

Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics

INTRODUCTION: Accurate costing is key for programme planning and policy implementation. Since 2011, there have been major changes in eligibility criteria and treatment regimens with price reductions in ART drugs, programmatic changes resulting in clinical task‐shifting and decentralization of ART de...

Descripción completa

Detalles Bibliográficos
Autores principales: Tucker, Austin, Tembo, Tannia, Tampi, Radhika P, Mutale, Jacob, Mukumba‐Mwenechanya, Mpande, Sharma, Anjali, Dowdy, David W, Moore, Carolyn B, Geng, Elvin, Holmes, Charles B, Sikazwe, Izukanji, Sohn, Hojoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025092/
https://www.ncbi.nlm.nih.gov/pubmed/32064766
http://dx.doi.org/10.1002/jia2.25431
_version_ 1783498479946956800
author Tucker, Austin
Tembo, Tannia
Tampi, Radhika P
Mutale, Jacob
Mukumba‐Mwenechanya, Mpande
Sharma, Anjali
Dowdy, David W
Moore, Carolyn B
Geng, Elvin
Holmes, Charles B
Sikazwe, Izukanji
Sohn, Hojoon
author_facet Tucker, Austin
Tembo, Tannia
Tampi, Radhika P
Mutale, Jacob
Mukumba‐Mwenechanya, Mpande
Sharma, Anjali
Dowdy, David W
Moore, Carolyn B
Geng, Elvin
Holmes, Charles B
Sikazwe, Izukanji
Sohn, Hojoon
author_sort Tucker, Austin
collection PubMed
description INTRODUCTION: Accurate costing is key for programme planning and policy implementation. Since 2011, there have been major changes in eligibility criteria and treatment regimens with price reductions in ART drugs, programmatic changes resulting in clinical task‐shifting and decentralization of ART delivery to peripheral health centres making existing evidence on ART care costs in Zambia out‐of‐date. As decision makers consider further changes in ART service delivery, it is important to understand the current drivers of costs for ART care. This study provides updates on costs of ART services for HIV‐positive patients in Zambia. METHODS: We evaluated costs, assessed from the health systems perspective and expressed in 2016 USD, based on an activity‐based costing framework using both top‐down and bottom‐up methods with an assessment of process and capacity. We collected primary site‐level costs and resource utilization data from government documents, patient chart reviews and time‐and‐motion studies conducted in 10 purposively selected ART clinics. RESULTS: The cost of providing ART varied considerably among the ten clinics. The average per‐patient annual cost of ART service was $116.69 (range: $59.38 to $145.62) using a bottom‐up method and $130.32 (range: $94.02 to $162.64) using a top‐down method. ART drug costs were the main cost driver (67% to 7% of all costs) and are highly sensitive to the types of patient included in the analysis (long‐term vs. all ART patients, including those recently initiated) and the data sources used (facility vs. patient level). Missing capacity costs made up 57% of the total difference between the top‐down and bottom‐up estimates. Variability in cost across the ten clinics was associated with operational characteristics. CONCLUSIONS: Real‐world costs of current routine ART services in Zambia are considerably lower than previously reported estimates and sensitive to operational factors and methods used. We recommend collection and monitoring of resource use and capacity data to periodically update cost estimates.
format Online
Article
Text
id pubmed-7025092
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70250922020-02-21 Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics Tucker, Austin Tembo, Tannia Tampi, Radhika P Mutale, Jacob Mukumba‐Mwenechanya, Mpande Sharma, Anjali Dowdy, David W Moore, Carolyn B Geng, Elvin Holmes, Charles B Sikazwe, Izukanji Sohn, Hojoon J Int AIDS Soc Research Articles INTRODUCTION: Accurate costing is key for programme planning and policy implementation. Since 2011, there have been major changes in eligibility criteria and treatment regimens with price reductions in ART drugs, programmatic changes resulting in clinical task‐shifting and decentralization of ART delivery to peripheral health centres making existing evidence on ART care costs in Zambia out‐of‐date. As decision makers consider further changes in ART service delivery, it is important to understand the current drivers of costs for ART care. This study provides updates on costs of ART services for HIV‐positive patients in Zambia. METHODS: We evaluated costs, assessed from the health systems perspective and expressed in 2016 USD, based on an activity‐based costing framework using both top‐down and bottom‐up methods with an assessment of process and capacity. We collected primary site‐level costs and resource utilization data from government documents, patient chart reviews and time‐and‐motion studies conducted in 10 purposively selected ART clinics. RESULTS: The cost of providing ART varied considerably among the ten clinics. The average per‐patient annual cost of ART service was $116.69 (range: $59.38 to $145.62) using a bottom‐up method and $130.32 (range: $94.02 to $162.64) using a top‐down method. ART drug costs were the main cost driver (67% to 7% of all costs) and are highly sensitive to the types of patient included in the analysis (long‐term vs. all ART patients, including those recently initiated) and the data sources used (facility vs. patient level). Missing capacity costs made up 57% of the total difference between the top‐down and bottom‐up estimates. Variability in cost across the ten clinics was associated with operational characteristics. CONCLUSIONS: Real‐world costs of current routine ART services in Zambia are considerably lower than previously reported estimates and sensitive to operational factors and methods used. We recommend collection and monitoring of resource use and capacity data to periodically update cost estimates. John Wiley and Sons Inc. 2020-02-17 /pmc/articles/PMC7025092/ /pubmed/32064766 http://dx.doi.org/10.1002/jia2.25431 Text en © 2020 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Tucker, Austin
Tembo, Tannia
Tampi, Radhika P
Mutale, Jacob
Mukumba‐Mwenechanya, Mpande
Sharma, Anjali
Dowdy, David W
Moore, Carolyn B
Geng, Elvin
Holmes, Charles B
Sikazwe, Izukanji
Sohn, Hojoon
Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics
title Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics
title_full Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics
title_fullStr Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics
title_full_unstemmed Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics
title_short Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics
title_sort redefining and revisiting cost estimates of routine art care in zambia: an analysis of ten clinics
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025092/
https://www.ncbi.nlm.nih.gov/pubmed/32064766
http://dx.doi.org/10.1002/jia2.25431
work_keys_str_mv AT tuckeraustin redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT tembotannia redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT tampiradhikap redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT mutalejacob redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT mukumbamwenechanyampande redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT sharmaanjali redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT dowdydavidw redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT moorecarolynb redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT gengelvin redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT holmescharlesb redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT sikazweizukanji redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics
AT sohnhojoon redefiningandrevisitingcostestimatesofroutineartcareinzambiaananalysisoftenclinics